Suppr超能文献

大麻素和内源性大麻素系统对恶心和呕吐的调节。

Regulation of nausea and vomiting by cannabinoids and the endocannabinoid system.

机构信息

Hotchkiss Brain Institute, Department of Physiology and Pharmacology, University of Calgary, 3330 Hospital Drive NW, Calgary, AB, Canada T2N 4N1.

Department of Basic Medical Sciences, College of Osteopathic Medicine of the Pacific, Western University of Health Sciences, Pomona, CA, USA.

出版信息

Eur J Pharmacol. 2014 Jan 5;722:134-46. doi: 10.1016/j.ejphar.2013.09.068. Epub 2013 Nov 1.

Abstract

Nausea and vomiting (emesis) are important elements in defensive or protective responses that animals use to avoid ingestion or digestion of potentially harmful substances. However, these neurally-mediated responses are at times manifested as symptoms of disease and they are frequently observed as side-effects of a variety of medications, notably those used to treat cancer. Cannabis has long been known to limit or prevent nausea and vomiting from a variety of causes. This has led to extensive investigations that have revealed an important role for cannabinoids and their receptors in the regulation of nausea and emesis. With the discovery of the endocannabinoid system, novel ways to regulate both nausea and vomiting have been discovered that involve the production of endogenous cannabinoids acting centrally. Here we review recent progress in understanding the regulation of nausea and vomiting by cannabinoids and the endocannabinoid system, and we discuss the potential to utilize the endocannabinoid system in the treatment of these frequently debilitating conditions.

摘要

恶心和呕吐(呕吐)是动物用来避免摄入或消化潜在有害物质的防御或保护反应的重要组成部分。然而,这些神经介导的反应有时表现为疾病的症状,并且经常被观察到是各种药物的副作用,特别是那些用于治疗癌症的药物。大麻长期以来被认为可以限制或预防各种原因引起的恶心和呕吐。这导致了广泛的研究,揭示了大麻素及其受体在调节恶心和呕吐方面的重要作用。随着内源性大麻素系统的发现,已经发现了调节恶心和呕吐的新方法,涉及中枢内源性大麻素的产生。在这里,我们回顾了近年来对大麻素和内源性大麻素系统调节恶心和呕吐的理解的进展,并讨论了利用内源性大麻素系统治疗这些经常使人衰弱的疾病的潜力。

相似文献

1
Regulation of nausea and vomiting by cannabinoids and the endocannabinoid system.
Eur J Pharmacol. 2014 Jan 5;722:134-46. doi: 10.1016/j.ejphar.2013.09.068. Epub 2013 Nov 1.
2
Regulation of nausea and vomiting by cannabinoids.
Br J Pharmacol. 2011 Aug;163(7):1411-22. doi: 10.1111/j.1476-5381.2010.01176.x.
4
5-HT3 receptors as important mediators of nausea and vomiting due to chemotherapy.
Biochim Biophys Acta. 2015 Oct;1848(10 Pt B):2738-46. doi: 10.1016/j.bbamem.2015.03.020. Epub 2015 Mar 30.
5
Looking beyond 5-HT(3) receptors: a review of the wider role of serotonin in the pharmacology of nausea and vomiting.
Eur J Pharmacol. 2014 Jan 5;722:13-25. doi: 10.1016/j.ejphar.2013.10.014. Epub 2013 Nov 2.
6
Medical Use of Cannabinoids.
Drugs. 2018 Nov;78(16):1665-1703. doi: 10.1007/s40265-018-0996-1.
7
Arvanil, anandamide and N-arachidonoyl-dopamine (NADA) inhibit emesis through cannabinoid CB1 and vanilloid TRPV1 receptors in the ferret.
Eur J Neurosci. 2007 May;25(9):2773-82. doi: 10.1111/j.1460-9568.2007.05521.x. Epub 2007 Apr 25.
8
[Review of cannabinoids in the treatment of nausea and vomiting].
Schmerz. 2004 Aug;18(4):306-10. doi: 10.1007/s00482-004-0315-5.
9
Receptor mechanism and antiemetic activity of structurally-diverse cannabinoids against radiation-induced emesis in the least shrew.
Eur J Pharmacol. 2007 Jun 1;563(1-3):187-96. doi: 10.1016/j.ejphar.2007.01.093. Epub 2007 Feb 16.
10
Aprepitant (EMEND): the role of substance P in nausea and vomiting.
J Pain Palliat Care Pharmacother. 2005;19(3):31-9.

引用本文的文献

2
Endocannabinoid signaling in stress, nausea, and vomiting.
Neurogastroenterol Motil. 2025 Mar;37(3):e14911. doi: 10.1111/nmo.14911. Epub 2024 Sep 2.
3
The Efficacy of Cannabis in Oncology Patient Care and Its Anti-Tumor Effects.
Cancers (Basel). 2024 Aug 21;16(16):2909. doi: 10.3390/cancers16162909.
5
The Basic Science of Cannabinoids.
Anesth Analg. 2024 Jan 1;138(1):42-53. doi: 10.1213/ANE.0000000000006472. Epub 2023 Dec 15.
6
Should gastroenterologists prescribe cannabis? The highs, the lows and the unknowns.
World J Clin Cases. 2023 Jun 26;11(18):4210-4230. doi: 10.12998/wjcc.v11.i18.4210.
7
Cannabis use and gastrointestinal tract illnesses: The National Health and Nutrition Examination Surveys, 2005-2018.
Drug Alcohol Rev. 2023 May;42(4):785-790. doi: 10.1111/dar.13609. Epub 2023 Feb 2.
8
Identification of Novel CB2 Ligands through Virtual Screening and In Vitro Evaluation.
J Chem Inf Model. 2023 Feb 13;63(3):1012-1027. doi: 10.1021/acs.jcim.2c01503. Epub 2023 Jan 24.
9
Cannabinoids as Prospective Anti-Cancer Drugs: Mechanism of Action in Healthy and Cancer Cells.
Adv Exp Med Biol. 2023;1410:145-169. doi: 10.1007/5584_2022_748.
10
Identification of CB1 Ligands among Drugs, Phytochemicals and Natural-Like Compounds: Virtual Screening and In Vitro Verification.
ACS Chem Neurosci. 2022 Oct 19;13(20):2991-3007. doi: 10.1021/acschemneuro.2c00502. Epub 2022 Oct 5.

本文引用的文献

1
Attenuation of anticipatory nausea in a rat model of contextually elicited conditioned gaping by enhancement of the endocannabinoid system.
Psychopharmacology (Berl). 2014 Feb;231(3):603-12. doi: 10.1007/s00213-013-3282-7. Epub 2013 Sep 17.
5
Neuronal mechanisms and the treatment of motion sickness.
Pharmacology. 2013;91(3-4):229-41. doi: 10.1159/000350185. Epub 2013 Apr 20.
6
Why can't rodents vomit? A comparative behavioral, anatomical, and physiological study.
PLoS One. 2013 Apr 10;8(4):e60537. doi: 10.1371/journal.pone.0060537. Print 2013.
7
Chemical probes of endocannabinoid metabolism.
Pharmacol Rev. 2013 Mar 19;65(2):849-71. doi: 10.1124/pr.112.006387. Print 2013 Apr.
9
Neuron-type specific cannabinoid-mediated G protein signalling in mouse hippocampus.
J Neurochem. 2013 Mar;124(6):795-807. doi: 10.1111/jnc.12137. Epub 2013 Feb 13.
10
Subacute to chronic mild traumatic brain injury.
Am Fam Physician. 2012 Dec 1;86(11):1045-51.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验